Primary spinal primitive neuroectodermal tumors (PNETs) are very rare conditions. Most of these tumors occur in children and young adults. A 63-year-old man with a primary spinal PNET in the conus medullaris from the L1 to L2 level is presented in this report. The optimal treatment of primary spinal PNETs is yet unknown. Surgical resection, radiation therapy, and chemotherapy have been advocated for the treatment of spinal PNET based on PNETs at other sites. However, the outcome is very poor. There are a few reports of cases with long-term survival and no recurrence. In these patients, en bloc resections were performed.
Introduction
Primitive neuroectodermal tumors (PNETs) are rare malignant neoplasms which occur predominantly in children and young adults. PNETs belong to the Ewing's sarcoma family of tumors and are associated with the same reciprocal chromosomal translocation as the Ewing's sarcoma.
PNETs usually develop in the cerebellum; however, they can also arise from other sites of the central nervous system (CNS) such as the cerebral hemispheres, cortex, pineal gland and brain stem. Primary spinal PNETs are very rare conditions, and up to now, only 38 cases have been reported in the literature . In this article, we report a rare case of a primary PNET of the conus medullaris in an elderly patient. The clinical, radiological and histological findings are presented and the relevant literature is reviewed.
Case Report
A previously healthy 63-year-old man was admitted to hospital with a 3 months' history of lower back pain projecting into the right leg. Spinal magnetic resonance imaging (MRI) demonstrated a disc hernia at the L2-L3 level and an intradural tumor from the L1 to L2 level ( fig. 1a-c) . After resection of the disc hernia, an intradural tumor resection was performed. The tumor was resected intralesionally because it was adhered to the spinal cord and nerve roots. Histopathological examination of the tumor specimen revealed a highly cellular, poorly differentiated neoplasm. The tumor was composed of small round cells with scanty cytoplasm and hyperchromatic nuclei. No well-defined Homer Wright and only a few ependymal rosettes were found ( fig. 2a) . Immunohistochemical staining for neuron-specific enolase (NSE) was strongly positive, as was staining for CD99 (MIC2) (fig. 2b ). On the other hand, there was no evidence of significant epithelial differentiation.
Two months after the operation, the patient complained of progressive paresthesia and weakness of the right leg and was referred to our hospital. Spinal MRI demonstrated an intraspinal tumor extending from the Th12 to L2 level. The tumor showed high intensity on both T1-( fig. 3a) and T2-weighted images ( fig. 3b ). The patient underwent chemotherapy with a protocol for Ewing's sarcoma family of tumors, because the results of the histopathological examination of the tumor led us to reject the diagnoses of lymphoma and poorly differentiated carcinoma and confirmed the diagnosis of PNET ( fig.  4) . Additionally, he received radiation therapy consisting of 16 Gy to the spinal cord and 14 Gy to the whole brain and spinal cord. After these treatments, his neurologic symptoms completely resolved and the tumor disappeared on MRI ( fig. 5a-c) .
The patient continued low-dose chemotherapy with etoposide; however, 21 months after the operation, he again experienced paresthesia and weakness of the right leg because of recurrence of the tumor. He was then treated with a multidrug chemotherapy again, but his symptoms did not improve. He died due to progressive paresis 25 months after the operation.
Discussion
Primary spinal PNETs are rare lesions. The majority of spinal PNETs are the result of subarachnoidal spread of tumors in the neuraxis. In 1973, the term PNET was first introduced by Hart and Earle [27] to describe undifferentiated cerebral tumors. Reviewing this term, in 1983, Rorke [28] defined PNETs as 'central nervous system tumors predominantly composed of undifferentiated neuroepithelial cells'. At the same time, they subclassified these tumors on the basis of their cellular differentiation. Finally, in 1993, the World Health Organization (WHO) classification grouped these tumors into the category of embryonal tumors composed of undifferentiated or less differentiated neuroepithelial cells which have the capacity of differentiation to astrocytes, ependymal cells, melanocytes or muscle cells [25] .
Histopathologically, PNETs are undifferentiated, small, round-cell tumors with hyperchromatic nuclei and features of neural differentiation, which typically form Homer Wright rosettes. The amount and quality of rosette formation vary substantially; some tumors may only show abortive rosette formation. On immunohistochemical examination, the most useful antibody for the diagnosis of PNET is the monoclonal antibody CD99, directed against the cell surface protein MIC2 whose gene is located on the pseudoautosomal region of the X and Y chromosomes. PNETs often have the same reciprocal chromosomal translocation, i.e. t(11;22)(q24;q12), which is the other key to the diagnosis of PNET [20] .
PNETs involving the spinal cord are most commonly drop metastases from primary intracranial tumors, which disseminate via the cerebrospinal fluid. Therefore, primary intraspinal PNETs are extremely rare, and to our knowledge, only 38 cases have been reported in the literature so far (table 1) . The age of the disease manifestation, including our case, ranged from 0 to 69 years, with an average age of 25.1 years. Our patient is the second oldest of all reported cases so far. In addition, there seems to be a male predominance for these tumors.
The optimal treatment of primary spinal PNETs is unknown because the tumors are very rare. Surgical resection, radiotherapy, and chemotherapy have been advocated for the treatment of spinal PNET based on PNETs at other sites. However, there is no agreement on the radiotherapy schedule, irradiance, and region (spine, brain, or both of them), as well as on the use and regimen of chemotherapy for PNETs. Successful results were reported using combinations of vincristine, doxorubicin, cyclophosphamide, ifosfamide and etoposide in Ewing's sarcoma. Despite multimodal treatment combining surgery, radiotherapy, and chemotherapy, the outcome is very poor. However, there are a few reports of cases with long-term survival and no recurrence. In these patients, en bloc resection was performed [20] .
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